6 Result(s)
-
Article
Open AccessClinical impact of volume of disease and time of metastatic disease presentation on patients receiving enzalutamide or abiraterone acetate plus prednisone as first-line therapy for metastatic castration-resistant prostate cancer
Metastatic castration-resistant prostate cancer remains a challenging condition to treat. Among the available therapeutic options, the androgen receptor signaling inhibitors abiraterone acetate plus prednisone...
-
Article
Author Correction: A global approach to improving penile cancer care
-
Article
A global approach to improving penile cancer care
Rare tumours such as penile carcinoma have been largely neglected by the urology scientific community in favour of more common — and, therefore, more easily fundable — diseases. Nevertheless, penile cancer rep...
-
Article
Revolutionizing care for rare genitourinary tumours
Management of rare genitourinary malignancies often depends on individual physicians’ discretion, resulting in non-standardized care. Furthermore, patients experience worse clinical outcomes than patients with...
-
Article
Targetable gene fusions and aberrations in genitourinary oncology
Gene fusions result from either structural chromosomal rearrangement or aberrations caused by splicing or transcriptional readthrough. The precise and distinctive presence of fusion genes in neoplastic tissues...
-
Article
Regenerative and engineered options for urethroplasty
Surgical correction of urethral strictures by substitution urethroplasty — the use of grafts or flaps to correct the urethral narrowing — remains one of the most challenging procedures in urology and is freque...
